Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lung cancer, non-small cell
Stage/Subtype:  stage I non-small cell lung cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 35 for your search:
Start Over
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CLI-PHO1601, NCI-2017-00430, NCT02916745
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A081105, NCI-2014-01508, CALGB A081105, NCT02193282
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: E4512, NCI-2014-01507, NCT02201992
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: BR31, NCI-2015-01967, IFCT1401, ACTRN12615000323527, NCT02273375
Sublobar Resection or Stereotactic Ablative Radiotherapy in Treating Patients with Stage I Non-small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: STU 022015-069, NCI-2015-01676, NCT02468024
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GO29527, NCI-2015-01731, 2014-003205-15, NCT02486718
Nivolumab after Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EA5142, NCI-2015-01916, NCT02595944
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: D5164C00001, NCI-2016-00551, 2015-000662-65, NCT02511106
Pulmonary Rehabilitation before Surgery in Improving Recovery in Patients with Non-small Cell Lung Cancer and Chronic Obstructive Pulmonary Disease
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: A221502, NCI-2016-01105, NCT02887521
Indocyanine Green Solution and Near-Infrared Fluorescence Imaging in Lymph Node Mapping in Patients with Stage I-II Non-small Cell Lung Cancer Undergoing Surgery
Status: Active
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 05-219, NCI-2012-00260, NCT00264602
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT)
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: 06-0691 / 201012832, NCI-2011-00543, 201012832, 06-0691, NCT00591838
Fresolimumab and Stereotactic Ablative Radiotherapy in Treating Patients with Stage IA-IB Non-small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUN0071, NCI-2015-01726, 4593, NCT02581787
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Status: Active
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, 302844, P08407, NCT00924027
Afatinib Dimaleate in Treating Patients with Stage I-III Non-small Cell Lung Cancer That Was Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-504, NCI-2013-01108, NCT01746251
Nivolumab with or without Ipilimumab in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 95
Trial IDs: J1414, NCI-2015-00243, CIR00010768, NA_00092076, NA_00092076/ J1414, NCT02259621
Metformin Hydrochloride in Treating Patients with Non-small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0255, NCI-2015-00287, NCT02285855
Atezolizumab, Nab-paclitaxel, and Carboplatin before Surgery in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AAAQ3153, NCI-2016-01097, NCT02716038
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ML39236, NCI-2016-01591, NCT02927301
Pembrolizumab before and after Surgery in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: Pro00071629, NCI-2017-00093, NCT02818920
TG4010 and Nivolumab in Treating Patients with Non-small Cell Lung Cancer Who Have Progressed after One Line of Systemic Therapy
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UCDCC#263, NCI-2016-00960, NCT02823990
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Status: Enrolling by invitation
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: INCB 18424-270, NCI-2017-00377, NCT02955940
Vaccine Therapy in Treating Patients with Non-small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-004, NCI-2014-01874, UPCI 08-004, NCT00793208
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Cisplatin, Docetaxel, and Nintedanib before Surgery in Treating Patients with Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0844, NCI-2014-02091, NCT02225405
4D CT Ventilation Image-Guided Personalized Radiation Therapy in Treating Patients with Lung Cancer or Lung Metastasis
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CCRO030, NCI-2015-01628, NCI-2015-01530, NCT02308709
Start Over